Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
15/11/2023 15:02
Nov 15 (Reuters) - Femasys Inc FEMY.O :
* PHARMACYTE BIOTECH ACQUIRES $5 MILLION STAKE IN EMERGING
WOMEN’S
HEALTH INNOVATOR FEMASYS, INC.
* PHARMACYTE BIOTECH INC - PHARMACYTE'S INTERIM CEO JOSH
SILVERMAN
WILL JOIN FEMASYS' BOARD OF DIRECTORS
Source text for Eikon: ID:nBw3Pr8n6a
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer